Pfizer expects to have data next month on how well its COVID-19 candidate vaccine protects people against the coronavirus.
Pfizer reports ‘potential’ of COVID-19 candidate vaccine after expanding trial to 44,000 people
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over